Cargando…
Pharmacokinetic Disposition Difference Between Cyclosporine and Voclosporin Drives Their Distinct Efficacy and Safety Profiles in Clinical Studies
BACKGROUND: Voclosporin, a more potent derivative of cyclosporine, has been studied extensively in patients with immunologic disorders such as psoriasis, organ transplantation, uvetitis and lupus nephritis. Although better tolerated and safer than cyclosporine, voclosporin is inferior to cyclosporin...
Autores principales: | Li, Yan, Palmisano, Maria, Sun, Duxin, Zhou, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335848/ https://www.ncbi.nlm.nih.gov/pubmed/32669879 http://dx.doi.org/10.2147/CPAA.S255789 |
Ejemplares similares
-
Clinical Pharmacokinetics and Pharmacodynamics of Voclosporin
por: Abdel-Kahaar, Emaad, et al.
Publicado: (2023) -
Voclosporin: First Approval
por: Heo, Young-A
Publicado: (2021) -
Pharmacokinetics and pharmacodynamics of nab-paclitaxel in patients with solid tumors: Disposition kinetics and pharmacology distinct from solvent-based paclitaxel
por: Chen, Nianhang, et al.
Publicado: (2014) -
Voclosporin as a Treatment for Noninfectious Uveitis
por: Schultz, Clyde
Publicado: (2013) -
Species difference in paclitaxel disposition correlated with poor pharmacological efficacy translation from mice to humans
por: Li, Ying Fei, et al.
Publicado: (2018)